1. From the Departments of Neurology and Epidemiology and Population Health, Albert Einstein College of Medicine, and Montefiore Medical Center — both in Bronx, NY (R.B.L.); Biohaven Pharmaceuticals, New Haven, CT (R.C., E.G.S., D.A.S., B.A.M., M.F., G.M.D., C.M.C., V.C.); NIHR–Wellcome Trust King’s Clinical Research Facility, King’s College Hospital–South London and Maudsley Biomedical Research Centre, King’s College London, London (P.J.G.); and the University of California, San Francisco, San Francisco (P...